46,193 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Acquired by AlphaQuest LLC

AlphaQuest LLC bought a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 46,193 shares of the company’s stock, valued at approximately $340,000.

Other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in shares of LifeStance Health Group by 26.8% during the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock valued at $24,170,000 after acquiring an additional 729,794 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after purchasing an additional 297,723 shares during the period. SG Americas Securities LLC grew its holdings in LifeStance Health Group by 65.7% during the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock valued at $666,000 after purchasing an additional 35,823 shares during the period. JPMorgan Chase & Co. increased its position in LifeStance Health Group by 13.0% in the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock worth $662,000 after buying an additional 10,894 shares in the last quarter. Finally, Point72 Asset Management L.P. raised its stake in shares of LifeStance Health Group by 24.9% in the third quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company’s stock worth $7,703,000 after buying an additional 219,329 shares during the period. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Stock Down 1.0 %

Shares of LFST opened at $6.92 on Friday. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a market capitalization of $2.66 billion, a PE ratio of -26.62 and a beta of 1.27. The business’s 50 day moving average is $7.80 and its 200 day moving average is $7.33.

Wall Street Analysts Forecast Growth

LFST has been the subject of several analyst reports. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, LifeStance Health Group presently has an average rating of “Hold” and an average price target of $8.63.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.